letrozole
← Previous: lenomorelin | 🏠 All Substances | 📊 Complete Table | Next: leuprorelin →
OPSS Properties
| Classifications | 6000 |
| Reason | WADA S4: Hormone and Metabolic ModulatorsPrescription drug |
| Also Known As |
|
| Prohibited Because | WADA S4: Hormone and Metabolic Modulators (WADA Prohibited List S4: Hormone and Metabolic Modulators) Prescription drug |
| Added to Database | December 30, 2025 |
| Source Last Updated | July 29, 2024 |
| GUID | 0f6166e9-eb19-41e8-840a-c322aac64b13 |
References
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 7LKK855W8I · CAS: 112809-51-5
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C17H11N5 |
| Molecular Weight | 285.30 g/mol |
| IUPAC Name | 4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile |
| InChIKey | HPJKCIUCZWXJDR-UHFFFAOYSA-N |
📊 Complete Table | 🏠 All Substances
Substance 498 of 880